Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!
A kind of enema pharmaceutical composition, preparation and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of composition and enema, applied in the direction of drug combination, drug delivery, antipyretic, etc.
Active Publication Date: 2020-05-22
胡一梅
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0007] Although blood stasis is the key to the above two pathologies, the above-mentioned enemas are all aimed at stagnation of Qi and blood stasis, and can also be combined with dampness suppression, hot burning, and Qi deficiency.
There are few existing treatments for pelvic inflammatory disease of the palace cold and blood stasis type
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0030] During implementation, the enema pharmaceutical composition can include the following components: Guizhi, Poria cocos, Salvia miltiorrhiza, red peony root, peach kernel, antler cream, Yuanhusuo, coix seed, Angelica dahurica, Eupatorium, Passepartout, raw astragalus, and It can be used in combination with other medicines to treat gynecological diseases of the uterine cold and blood stasis type according to the principle of TCM combination.
Embodiment 2
[0032] Enema pharmaceutical composition, by weight, consists of 15 parts of cassia twig, 15 parts of poria cocos, 15 parts of salvia miltiorrhiza, 15 parts of red peony root, 15 parts of peach kernel, 15 parts of antler cream, 15 parts of rhubarb, 18 parts of coix seed, 15 parts of angelica dahurica 15 parts of Zeilan, 15 parts of Passepartout, and 25 parts of Raw Astragalus.
Embodiment 3
[0034] Enema pharmaceutical composition, by weight, consists of 15 parts of cassia twig, 15 parts of poria cocos, 15 parts of salvia miltiorrhiza, 15 parts of red peony root, 15 parts of peach kernel, 15 parts of antler cream, 15 parts of rhubarb, 20 parts of coix seed, 15 parts of angelica dahurica 15 parts of Zeilan, 15 parts of Passepartout, and 30 parts of Raw Astragalus.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a pharmaceutical composition used for enema. The pharmaceutical composition used for enema comprises the following components: cassia twig, poria cocos, salviae miltiorrhizae, red peony root, peach kernel, cornu cervi degelatinatum, rhizoma corydalis, coix seeds, angelica root, lycopus lucidus, beautiful sweetgum fruits and raw radix astragalis. The invention also discloses a preparation and application. The pharmaceutical composition disclosed by the invention cortex moutan is eliminated on the basis of a cassia twig-poria cocos pill, a drug combination of warming uterus and activating blood, removing blood stasis and stopping pain of dysmenorrheal is added, and the effects of harmonizing yin and yang, warming meridians and dredging vessels, activating blood and removing blood stasis as well as eliminating symptoms and stopping pain can be effectively achieved.
Description
technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to an enema pharmaceutical composition, preparation and application thereof. Background technique [0002] Pelvic inflammatory disease is pelvic inflammatory disease, which refers to the inflammation of female pelvic reproductive organs (including uterus, fallopian tubes, ovaries), connective tissue around the uterus and pelvic peritoneum. Chronic pelvic inflammatory disease is often caused by incomplete treatment in the acute phase, and its onset time is long and the condition is more stubborn. Bacteria retrograde infection, through the uterus, fallopian tubes and reach the pelvic cavity. But in real life, not all women will suffer from pelvic inflammatory disease, and the incidence is only a minority. This is because the female reproductive system has a natural defense function. Under normal circumstances, it can resist the invasion of bacteria. Only when the body's r...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.